BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38363781)

  • 1. Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
    Kanitthamniyom C; Wannaphut C; Pattanaprichakul P; Kungwankiattichi S; Owattanapanich W
    PLoS One; 2024; 19(2):e0297805. PubMed ID: 38363781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.
    Wang CX; Pusic I; Anadkat MJ
    JAMA Dermatol; 2019 Jul; 155(7):826-832. PubMed ID: 30969325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
    Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
    Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
    Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
    Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
    [No Abstract]   [Full Text] [Related]  

  • 6. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
    Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
    Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
    Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
    Renaud J; Goemans BF; Locatelli F; Pigazzi M; Redmond S; Kuehni CE; Destaillats A; Alonzo TA; Gerbing RB; Gamis A; Aplenc R; Renella R; Cooper T; Ceppi F
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31006. PubMed ID: 38616361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.
    Kaddu S; Zenahlik P; Beham-Schmid C; Kerl H; Cerroni L
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):966-78. PubMed ID: 10365929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
    Huang YJ; Zhang JH; Dong CX; Kang JM; Hou YF; Zhang YF; Qi K; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1361-1368. PubMed ID: 36208236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia.
    Byrd JC; Edenfield WJ; Dow NS; Aylesworth C; Dawson N
    Leuk Lymphoma; 1996 Mar; 21(1-2):153-9. PubMed ID: 8907283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and prognosis in adult acute myeloid leukemia patients with MLL gene rearrangements].
    Gong XY; Wang Y; Liu BC; Wei H; Li CW; Li QH; Zhao JW; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Li Y; Gu RX; Qiu SW; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jan; 39(1):9-14. PubMed ID: 29551026
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemia cutis as the presenting symptom of acute myeloid leukemia: report of three cases.
    Moyer AB; Rembold J; Lee NE; Johnson G; Gardner JM
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.
    Pastore F; Dufour A; Benthaus T; Metzeler KH; Maharry KS; Schneider S; Ksienzyk B; Mellert G; Zellmeier E; Kakadia PM; Unterhalt M; Feuring-Buske M; Buske C; Braess J; Sauerland MC; Heinecke A; Krug U; Berdel WE; Buechner T; Woermann B; Hiddemann W; Bohlander SK; Marcucci G; Spiekermann K; Bloomfield CD; Hoster E
    J Clin Oncol; 2014 May; 32(15):1586-94. PubMed ID: 24711548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
    Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
    Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical features and prognosis of core binding factor acute myeloid leukemia children in South China: a multicenter study].
    Guo BY; Wang Y; Li J; Li CF; Feng XQ; Zheng MC; Liu SX; Yang LH; Jiang H; Xu HG; He XL; Wen H
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):881-888. PubMed ID: 37803854
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemia cutis and other dermatological findings in pediatric patients with acute myeloid leukemia.
    Godínez-Chaparro JA; Valencia-Herrera AM; Duarte-Abdala MR; Mena-Cedillos CA; Toledo-Bahena ME
    Bol Med Hosp Infant Mex; 2021; 78(5):411-417. PubMed ID: 34571521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukemia cutis: clinical features of 27 mexican patients and a review of the literature].
    Peña-Romero AG; Domínguez-Cherit J; Méndez-Flores S
    Gac Med Mex; 2016; 152(5):439-443. PubMed ID: 27792708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.